COVID-19 Outcomes in Solid Organ Transplant Recipients Who Received Tixagevimab-cilgavimab Prophylaxis and/or Bebtelovimab Treatment in a Nurse-driven Monoclonal Antibody Program During the Omicron Surge. Issue 2 (13th October 2022) - Cochran, Willa; Salto-Alejandre, Sonsoles; Barker, Lindsay; Langlee, Julie; Freed, Kristin; Carter, Debra; Bannon, Jaclyn; Goddard, Dillon; Mostafa, Heba; Werbel, William; Shah, Pali; Segev, Dorry; et al.